A federal advisory panel on Thursday recommended against approval of a new diet pill, the latest setback in efforts to develop treatments for the nation’s obesity epidemic.

The advisers to the Food and Drug Administration voted 9 to 5 that the potential benefits of the drug, called lorcaserin and developed by Arena Pharmaceuticals, did not outweigh the risks.

Diet Drug From Arena Rejected by F.D.A. Panel – NYTimes.com

Fat Thanks to Sunita K. for the tip!